CompletedPhase 4NCT02125721
Effect of Increasing Doses of Cystine Binding Thiol Drugs on Cystine Capacity in Patients With Cystinuria
Studying Cystinuria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- NYU Langone Health
- Principal Investigator
- David S Goldfarb, MD, M.DNYU Langone Medical Center
- Intervention
- Tiopronin 1g per day(drug)
- Enrollment
- 10 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2012 – 2017
Study locations (1)
- NYU Langone Medical Center, New York, New York, United States
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02125721 on ClinicalTrials.govOther trials for Cystinuria
Additional recruiting or active studies for the same condition.